Understanding Health Care Provider Attitudes Ahead of Advisory Committee on Immunization Practices (ACIP) Recommendations

syringe and vaccine vials

Cross-Sectional Survey of Pneumococcal Vaccine Prescribers


This study revealed that the majority of HCPs wanted the 2014 recommendations to remain indefinitely or to remain with a scheduled reconsideration. Subsequently, the published findings on HCP preferences were cited by ACIP in its Evidence to Recommendation framework for pneumococcal vaccine among adults ≥ 65 years old.


The CDC’s Advisory Committee on Immunization Practices (ACIP) takes stakeholder acceptability into consideration when establishing recommendations. To anticipate the potential for changes to the CDC’s ACIP recommendations ahead of a recent update, our client was interested in gaining a better understanding of healthcare provider (HCP) knowledge, attitudes, beliefs, and preferences for potential changes to pneumococcal disease immunization recommendations among adults aged ≥ 65 years.


  • We conducted a cross-sectional survey among US HCPs who prescribe and administer pneumococcal vaccine to adults aged ≥ 65 years
  • Our researchers applied object-case best-worst scaling to assess HCP preferences among potential recommendation scenarios
  • We identified 1,000 HCPs enrolled in a national provider panel who completed the survey
  • Our team analyzed and summarized the results of the survey and subsequently published the results